Clinical experience with zidovudine for patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex
References (13)
- et al.
Response of human immunodeficiency virus associated disease to 3′-azido-3′-deoxythymidine
Lancet
(1987) - et al.
Zidovudine for lymphocytic pneumonitis in AIDS
Lancet
(1987) - et al.
Acute meningo-encephalitis on dose-reduction of zidovudine
Lancet
(1988) - et al.
Zidovudine-associated myopathy
Lancet
(1988) - et al.
Necrotising myopathy and zidovudine
Lancet
(1988) - et al.
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex
New Engl J Med
(1987)
There are more references available in the full text version of this article.
Cited by (43)
Neurologic Complications of HIV and AIDS
2004, AIDS and Other Manifestations of HIV InfectionAZT decreases rat myocardial cytochrome oxidase activity and increases β-myosin heavy chain content
1998, Journal of Molecular and Cellular CardiologyThe Concorde trial
1993, The LancetAntiretroviral therapy in combination with interferon for AIDS-related Kaposi's sarcoma
1991, The American Journal of Medicine
Copyright © 1989 Published by Elsevier Ltd.